Test License [Regulatives / Guidelines]

posted by rajasekharkakarla – India, 2018-10-06 08:05  – Posting: # 19411
Views: 943

Dear All,

I applied Test license for some X drug in India, I got permission and I imported the drug (reference) from outside India then conducted one study (pilot). Now I want to conduct one more study (pivotal) with remaining quantity of Reference drug from first study. Here I have some doubts:

1) Can I use remaining quantity of reference drug for pivotal

2) If we use remaining IPs, Is we need to get Test license permission for pivotal.

or

Is we need to apply fresh Test license to import Reference drug separately for pivotal.

Please guide me to overcome this issue.

Regards,
RK

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,545 posts in 4,145 threads, 1,340 registered users;
online 11 (0 registered, 11 guests [including 7 identified bots]).
Forum time (Europe/Vienna): 09:34 CEST

Anyone who has never made a mistake
has never tried anything new.    Albert Einstein

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5